Cisen Pharmaceutical Ltd. Class ASSE: 603367

"Cisen Pharmaceutical Co., Ltd."Announcement on a Subsidiary's Receipt of the First Generic Approval for Marketing of Its Loteprednol Etabonate and Tobramycin Eye Drops

· Issued by Cisen Pharmaceutical Ltd. Class A via Shanghai Stock Exchange

Filed with SSE ·

Announcement on a Subsidiary's Receipt of the First Generic Approval for Marketing of Its Loteprednol Etabonate and Tobramycin Eye Drops

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Cisen Pharmaceutical Ltd. Class A

All Cisen Pharmaceutical Ltd. Class A news releases